Sep 10, 2019 02:06 PM IST
Index of Industrial Production and Consumer Price Index data will be released on September 12.
- Aug 21, 2019 08:57 PM IST
Founded in 2016, Biocon Biologics India (BBIL) is reported to be the fastest-growing division within Biocon, with a 97 percent growth in revenue to Rs 1,516 crore in FY19 compared to FY18.
- Aug 01, 2019 09:00 PM IST
The company will be selling the drug under brand name Ogivri, which will be used for the treatment of HER2 sub-type breast cancer and metastatic stomach cancer.
- Jul 26, 2019 04:01 PM IST
ICICI Direct is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 330 in its research report dated July 26, 2019.
- Jul 26, 2019 12:01 PM IST
- Jul 26, 2019 12:01 PM IST
- Jul 19, 2019 03:36 PM IST
The biosimilar launched by Amgen and Allergan hit the Biocon scrip, which dropped 8.17 percent and was trading at Rs 241.55 on the BSE at 3 pm.
- Jul 16, 2019 08:48 AM IST
Trends on SGX Nifty indicate a flat to negative opening for the broader index in India, a fall of 7.5 points or 0.06 percent. Nifty futures were trading around 11,539-level on the Singaporean Exchange.
- Jul 08, 2019 01:31 PM IST
As per the USFDA, the Form 483 notifies the company's management of objectionable conditions after the conclusion of an inspection.
- Jun 14, 2019 04:45 PM IST
The European agency inspected Bengaluru unit in March 2019.
- Apr 30, 2019 11:18 AM IST
At 1114 hrs, Biocon was quoting Rs 606.50, down 2.15 percent on the BSE.
- Apr 26, 2019 04:12 PM IST
ICICI Direct is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 730 in its research report dated April 26, 201
- Apr 26, 2019 10:15 AM IST
- Apr 26, 2019 10:13 AM IST
- Apr 25, 2019 09:01 PM IST
Total revenue during the quarter grew by 26 percent to Rs 1,557 crore.
- Apr 17, 2019 03:12 PM IST
Net Sales are expected to increase by 31.6 percent Y-o-Y (down 0.1 percent Q-o-Q) to Rs. 1,538.7 crore, according to Kotak.
- Mar 06, 2019 08:09 PM IST
'The inspection at the Bengaluru facility took place between February 25-March 5, resulting in a Form 483 with six observations,' it added.
- Mar 01, 2019 09:03 PM IST
Hamacher comes with more than 20 years of leadership experience in both strategic and operational roles across the value chain in global pharma spanning Asia, Europe and the US, Biocon said in a BSE filing.
- Feb 08, 2019 07:37 AM IST
Biocon is at the confluence of multiple technical indicators and post a smart rally
- Jan 28, 2019 11:19 AM IST
ICICI Direct is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 760 in its research report dated January 25, 2019.
- Jan 25, 2019 11:07 AM IST
Biocon's Q3 net profit more than doubled, rising 136.34 percent YoY to Rs 217.2 crore.
- Jan 24, 2019 06:40 PM IST
Revenues from the biologics vertical, that comprises biosimilars, rose 136 percent to Rs 449 crore driven by the biosimilar Pegfilgrastim gaining market share in the US.
- Jan 24, 2019 06:25 PM IST
- Jan 24, 2019 06:24 PM IST
- Jan 21, 2019 08:25 AM IST
A billionaire entrepreneur and founder of the country's leading biotechnology firm Biocon, Mazumdar gave this suggestion to the Congress during the party's 'manifesto consultation meeting on IT and BT Economy', chaired by P Chidambaram here.